MMS
Buying intent
52 tracked signals | Top 15 topics are below | Sales and Engineering are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere MMS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
18d ago
18d ago
19d ago
24d ago
18d ago
19d ago
18d ago
26d ago
18d ago
31d ago
18d ago
24d ago
20d ago
19d ago
27d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at MMS
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
12 people across every department at MMS, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileMMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, a 20-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO part
New capability sought
Employee posts (LinkedIn)Hiring; Conference; Data Science; Thermo Fisher Scientific
Top accounts researching MMS
names withheld on the public pageThese are companies whose own people brought up MMS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
6,459 companies · 25,813 people are researching Pharmaceutical
MMS's own team shows 8 signals on this topic. No one outside MMS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Clinical Trials4,086 cos · 17,225 people
- Clinical Data Management210 cos · 761 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people; HR / Talent — 2 people; Engineering — 1 person; Operations — 1 person; Leadership — 1 person
What's been said
public posts by MMS's teamNo public post naming MMS has surfaced in the past year, so this is what MMS's own team is posting about publicly — their topics, in their words.
Every time the Roman emperor Marcus Aurelius returned victorious from war, amidst all the applause, celebrations, and praise, an attendant would whisper just five words into his ear: “Remember, you will die one day.” And remarkably, Marcus himself had instructed the attendant to do this. Not to be morbid. Not to diminish success. But to stay grounded. The Stoics called it Memento Mori — remembering that life is temporary. In today’s corporate world, this principle feels more relevant than ever. Titles change. Cabins change. Org charts change. Power shifts. The people applauding you today may move on tomorrow. And somewhere in the race for targets, promotions, visibility, and recognition, many leaders unknowingly lose something far more valuable: their humility, their relationships, their kindness, their humanity. When we remember that all of us are temporary visitors in this journey called life, something shifts. Egos become smaller. Listening becomes easier. Gratitude becomes deeper. People matter more than positions. Ironically, the leaders who remember their own impermanence often leave behind the strongest legacy. Not because they were feared. But because they were respected. Not because they were powerful. But because they made others feel valued. At the end of the day, very few people will remember our designation. But they will always remember how we made them feel. That, perhaps, is the real leadership lesson behind Memento Mori. #Leadership #Humility #LeadershipLessons #EmotionalIntelligence #ExecutivePresence #Culture #GrowthMindset #hrmusings #nandinivijaisimha
May 2026Pennsylvania is suing Character.AI after chatbot characters allegedly presented themselves as licensed medical professionals, including psychiatrists. In one case, a chatbot allegedly claimed to be licensed in Pennsylvania and gave an invalid licence number. Accuracy is only one part of the problem but the harder issue is representation. If an AI system can make a user believe they are interacting with a licensed professional, the governance question changes: What was the AI allowed to claim about itself? What professional-status language was blocked, monitored or escalated? And who owned that interaction once the user relied on it? As AI systems move into triage, support, advice, drafting and investigation workflows, organisations will need to evidence more than “a human was available” or “the model has guardrails”. Instead of asking “was AI used?” The question has moved to: “what did the AI lead the user to believe?” #AIGovernance #AIAccountability #HealthTech #AIRegulation #DigitalTrust
May 2026